Executive Summary
This one-day Contract Deobligations Alert reveals $2.9B in sustained federal obligations across 18 contracts, predominantly bullish for IT/services firms with Leidos capturing 39% ($1.13B total) via SSA and DHS awards. Long-term revenue visibility dominates, with 15 contracts extending beyond 2026 (up to 2033) and $2.1B+ in unexercised options signaling upside. Risks cluster around firm fixed price exposure (12/18 contracts) amid high outlays ($1.7B+ already spent), favoring public defense/IT names like Leidos, General Dynamics, and Oracle over nonprofits.
Tracking the trend? Catch up on the prior Contract Deobligations Alert digest from March 17, 2026.
Investment Signals(4)
- Leidos dominates civilian/defense IT with $1.13B obligations(HIGH)β²
Leidos secures top two awards ($1.06B SSA IT management + $67M DHS maintenance), with $906M outlayed and $324M options, underscoring multi-year backlog growth.
- DHS border/security contracts boost detection firms(HIGH)β²
Five DHS awards total $474M (Rapiscan $186M, Smiths $77M, Steampunk $75M, GD IT $68M, Leidos $67M), with 58% outlayed and extensions to 2031+.
- VA health IT/supplies pipeline intact at $382M(MEDIUM)β²
Oracle ($176M EHRM), Deloitte ($67M cyber), Medline ($138M dual-month supplies) show committed VA spend through 2029, despite $0 outlay on future Medline periods.
- Nonprofits absorb $163M with limited equity impact(HIGH)β²
Caltech ($85M NASA) and US Refugees ($78M DOI) fully funded through 2026, but nonprofit status mutes investor relevance.
Risk Flags(3)
- Execution[HIGH RISK]βΌ
Firm fixed price on 12/18 contracts ($2.1B value) exposes winners to cost overruns without reimbursement, especially long-duration awards (avg. potential end 2028).
- Market[MEDIUM RISK]βΌ
Unexercised options total $2.1B+ (72% of base+options premiums), vulnerable to agency non-exercise amid budget scrutiny.
- Competitive[MEDIUM RISK]βΌ
Non-competed awards (4/18, $427M) to Leidos, Oracle, GD signal sole-source reliance, risking future recompetes.
Opportunities(3)
- β
$2.1B unexercised options + 10 extensions to 2029-2033 offer 70%+ upside on $2.9B base obligations.
- β
IT/services (NAICS 5415xx) comprise 10/18 contracts ($1.6B, 55%), with DHS/VA/HHS prioritizing cyber/EHRM/border tech.
- β
High outlays ($1.7B, 59% of obligations) on 14 contracts indicate derisked cash flow visibility through 2027.
Sector Themes(3)
- β
9/18 contracts ($1.5B) in IT/telecom (PSC D*) from DHS/VA/HUD/SSA signal steady civilian/defense demand despite deobligation watch.
- β
DHS detection/maintenance awards ($408M to Rapiscan/Smiths/Leidos) extend to 2031+, reflecting sustained CBP capex.
- β
HHS/VA/CMS spend ($843M across 7 awards) on labs/insurance/supplies underscores non-discretionary fed health outlays.
Watch List(4)
- π
{"entity"=>"Leidos (LDOS)", "reason"=>"39% of period value ($1.13B); $324M options + dual-agency exposure amplify backlog impact.", "trigger"=>"SSA/DHS option exercises >$200M"}
- π
{"entity"=>"DHS CBP Pipeline", "reason"=>"5 contracts ($474M, 16% total) with 2031 extensions signal border tech surge.", "trigger"=>"New RFPs for RDE/NII post-2027"}
- π
{"entity"=>"Oracle VA EHRM", "reason"=>"$608M options on $176M obligation; non-competed health IT prone to follow-ons.", "trigger"=>"Outlay ramp >$50M in H1 2026"}
- π
{"entity"=>"Medline Industries (dual VA awards)", "reason"=>"$138M future-dated supplies (Jan/Feb 2026, $0 outlay) test repeat vendor momentum.", "trigger"=>"March 2026 outlay confirmation"}
Get daily alerts with 4 investment signals, 3 risk alerts, 3 opportunities and full AI analysis of all 18 filings
πΊπΈ More from United States
View all βMarch 25, 2026
US Pre-Market SEC Filings Roundup β March 25, 2026
US Pre-Market SEC Filings Roundup
March 24, 2026
US Merger & Acquisition SEC Filings β March 24, 2026
US Merger & Acquisition SEC Filings
March 24, 2026
US Corporate Board Director Changes SEC Filings β March 24, 2026
US Corporate Board Director Changes SEC Filings
March 24, 2026
US Executive Officer Management Changes SEC β March 24, 2026
US Executive Officer Management Changes SEC